BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 105 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2016. The put-call ratio across all filers is 6.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $353,000 | -8.5% | 114,000 | +6.5% | 0.13% | -10.6% |
| Q3 2021 | $386,000 | -2.8% | 107,000 | -3.6% | 0.14% | +0.7% |
| Q2 2021 | $397,000 | +7.9% | 111,000 | +18.1% | 0.14% | -0.7% |
| Q1 2021 | $368,000 | -2.6% | 94,000 | +4.6% | 0.14% | +1.4% |
| Q4 2020 | $378,000 | +60.2% | 89,900 | +41.8% | 0.14% | +42.9% |
| Q3 2020 | $236,000 | +7.3% | 63,400 | +25.8% | 0.10% | 0.0% |
| Q2 2020 | $220,000 | +16.4% | 50,400 | -40.0% | 0.10% | -14.8% |
| Q1 2018 | $189,000 | -23.8% | 83,973 | 0.0% | 0.12% | -25.3% |
| Q4 2017 | $248,000 | 0.0% | 83,973 | 0.0% | 0.15% | -24.9% |
| Q3 2017 | $248,000 | +5.5% | 83,973 | 0.0% | 0.20% | +49.6% |
| Q2 2017 | $235,000 | +2.6% | 83,973 | -30.5% | 0.14% | +16.1% |
| Q1 2017 | $229,000 | -54.4% | 120,766 | -57.9% | 0.12% | -17.5% |
| Q4 2016 | $502,000 | -76.9% | 286,642 | -64.3% | 0.14% | -68.4% |
| Q3 2016 | $2,170,000 | +15.0% | 803,810 | +0.5% | 0.45% | -3.6% |
| Q2 2016 | $1,887,000 | +26.1% | 799,572 | +72.5% | 0.47% | +0.9% |
| Q1 2016 | $1,497,000 | +5.1% | 463,598 | +55.9% | 0.46% | +23.7% |
| Q4 2015 | $1,425,000 | -12.3% | 297,445 | +1.7% | 0.38% | -13.0% |
| Q3 2015 | $1,625,000 | -3.2% | 292,330 | +38.6% | 0.43% | +37.1% |
| Q2 2015 | $1,678,000 | +12.5% | 210,857 | +48.4% | 0.32% | +19.3% |
| Q1 2015 | $1,492,000 | +33.5% | 142,126 | +52.8% | 0.26% | +46.7% |
| Q4 2014 | $1,118,000 | -29.6% | 92,993 | 0.0% | 0.18% | -11.8% |
| Q3 2014 | $1,589,000 | -10.0% | 92,993 | -36.4% | 0.20% | +9.1% |
| Q2 2014 | $1,766,000 | -12.0% | 146,289 | -38.5% | 0.19% | -19.4% |
| Q1 2014 | $2,006,000 | +41.1% | 237,719 | -1.6% | 0.23% | +28.9% |
| Q4 2013 | $1,422,000 | +21.1% | 241,519 | +11.7% | 0.18% | -5.3% |
| Q3 2013 | $1,174,000 | +78.4% | 216,263 | +33.4% | 0.19% | +46.2% |
| Q2 2013 | $658,000 | – | 162,148 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |